ClinicalTrials.gg
Not yet recruitingNCT07591636Updated May 18, 2026

ACT Dad Interview: ACT for Fathers of Children With Special Needs

An observational study in Caregiver Mental Health, Parenting Stress and Developmental Disabilities, sponsored by The Hong Kong Polytechnic University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by The Hong Kong Polytechnic University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
20
Sex
All
01

Study summary

The goal of this qualitative study is to develop a therapy protocol for fathers of children with special needs in Hong Kong. The therapy is called Acceptance and Commitment Therapy (ACT), which helps people cope with difficult emotions by building psychological flexibility - the ability to accept and adjust to hard situations. The main questions it aims to answer are:

  1. What are the experiences and needs of fathers raising children with special needs?
  2. What content and format of an ACT programme would be most helpful for these fathers?

Researchers will conduct focus group interviews with two groups of participants: fathers raising children with special needs and social workers who work with these families. The interviews will take about 60 to 90 minutes each.

Participants will:

  1. Take part in a recorded focus group interview
  2. Share their experiences, challenges, and views on what an ACT program should include

The findings will be used to develop a protocol for an ACT programme to improve the mental health of fathers raising children with special needs.

02

Conditions studied

  • Caregiver Mental Health
  • Parenting Stress
  • Developmental Disabilities
  • Special Needs Children
  • FATHER

Keywords

  • mental health
  • Father
  • psychological flexibility
  • Acceptance and Commitment Therapy
  • Qualitative Study
  • Special Needs
03

In context

Developmental Disabilities

230 studies on the registry are indexed under Developmental Disabilities; 65 are open to participants now.

This study's planned enrollment of 20 is below the median of 216 across 74 observational studies indexed under Developmental Disabilities.

Browse Developmental Disabilities studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 679 studies on the registry; 257 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Biological fathers of children aged 2 to 12 years with a formal diagnosis of a developmental disability (including autism spectrum disorder, ADHD, or intellectual disability), and social workers with experience working with these families. All participants are able to speak Cantonese and read Chinese.

Eligibility criteria

Informants will include 2 groups, 1) fathers rearing children with special needs and 2) social workers.

For fathers,

Inclusion Criteria:

  1. are the biological fathers of children aged 2 to 12 years,
  2. are with a child having a formal diagnosis of a developmental disability, including autism spectrum disorder, attention deficit/hyperactivity disorder, intellectual disability, or related neurodevelopmental conditions,
  3. are able to speak Cantonese and read Chinese.

Exclusion Criteria:

  1. Fathers with physical or cognitive impairment
  2. Father with learning problems as identified from NGO or related medical records

For social workers,

Inclusion Criteria:

  1. have experience in working with biological fathers of children aged 2 to 12 years who have a formal diagnosis of a developmental disability, including autism spectrum disorder, attention deficit/hyperactivity disorder, intellectual disability, or related neurodevelopmental conditions,
  2. are able to speak Cantonese and read Chinese.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
20 participants (estimated)
Patient registry
No

Groups and cohorts

  • SEN father and social workers

    Other: Semi-structured Focus Group Interview

Interventions

  • OtherSemi-structured Focus Group Interview

    Participants will take part in a 60 to 90-minute, video-recorded, semi-structured focus group interview conducted in Cantonese.

06

What researchers measure

Primary outcomes

  1. Psychological flexibility

    Qualitative method, conducted in the form of individual semi-structured interviews.

    Time frame: immediately after the interview

  2. Mental Health

    Qualitative method, conducted in the form of individual semi-structured interviews.

    Time frame: immediately after the interview

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07591636
Responsible party
Dr Katherine Lam (Assistant Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
May 18, 2026
Start date
May 1, 2026 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
May 18, 2026

Study contacts

Ka Wai Katherine LAM, Doctor of Philosophy
Contact
kw-katherine.lam@polyu.edu.hk
+852 27666420

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion